Emerging Medical Treatment for Hypertrophic Cardiomyopathy

Emerging Medical Treatment for Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy (HCM) is a common myocardial disease characterized by otherwise unexplained left ventricular hypertrophy. The main cause of disabling symptoms in patients with HCM is left ventricular outflow tract (LVOT) obstruction. This phenomenon is multifactorial, determined both by...

Full description

Bibliographic Details
Main Authors: Alessia Argirò, Mattia Zampieri, Martina Berteotti, Alberto Marchi, Luigi Tassetti, Chiara Zocchi, Luisa Iannone, Beatrice Bacchi, Francesco Cappelli, Pierluigi Stefàno, Niccolò Marchionni, Iacopo Olivotto
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Journal of Clinical Medicine
Subjects:
hypertrophic cardiomyopathy
left ventricular outflow tract obstruction
mavacamten
septal reduction therapy
Online Access:https://www.mdpi.com/2077-0383/10/5/951

Internet

https://www.mdpi.com/2077-0383/10/5/951

Similar Items